Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-15

FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Effexor XR (venlafaxine)

Snippet

SUPPL AP for EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)